Soni Medicare

Which are the latest news on Soni Medicare?

Why is Soni Medicare Ltd falling/rising?

As of 05-Sep, Soni Medicare Ltd's stock price is at 69.35, unchanged from the previous day, reflecting a significant decline of -24.63% over the past year and ongoing financial struggles with negative results for four consecutive quarters. The stock has opened with a loss of -4.99% today, indicating low investor confidence and poor trading performance.

As of 05-Sep, Soni Medicare Ltd's stock price is currently at 69.35, with no change from the previous day. The stock has shown a significant decline over the past year, with a return of -24.63%, while its profits have fallen by an alarming -402%. This trend is compounded by the company's negative results for the last four consecutive quarters, indicating ongoing financial struggles.<BR><BR>Today, the stock opened with a loss of -4.99% and has not traded above its opening price, reflecting a lack of investor confidence. Additionally, the stock has underperformed its sector by -5.56% today and has not traded on 5 out of the last 20 days, indicating erratic trading behavior. The delivery volume has also decreased by -11.56% against the 5-day average, suggesting falling investor participation.<BR><BR>The company's financial health is concerning, as it has a negative book value and a high debt to EBITDA ratio of -12.95 times, which indicates a low ability to service its debt. Furthermore, the return on equity is only 1.73%, signifying low profitability per unit of shareholders' funds. The stock's performance relative to benchmarks shows that while it has gained +8.72% over the past month, it still lags behind the Sensex, which has declined by -2.44%.<BR><BR>Overall, the combination of poor financial results, declining investor interest, and negative trading patterns contributes to the stock's downward trajectory.

Who are in the management team of Soni Medicare?

The management team of Soni Medicare includes Anju Soni (Director), Bimal Roy Soni (Chairman & Managing Director), Mahavir Prasad Yadav, Mamta Sharma, and Naveen Sanghi (all Independent Directors), along with Juhi Gurnani (Company Secretary & Compliance Officer).

The management team of Soni Medicare includes the following individuals:<BR><BR>1. **Anju Soni** - Director<BR>2. **Bimal Roy Soni** - Chairman & Managing Director<BR>3. **Mahavir Prasad Yadav** - Independent Director<BR>4. **Mamta Sharma** - Independent Director<BR>5. **Naveen Sanghi** - Independent Director<BR>6. **Juhi Gurnani** - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Soni Medicare do?

Soni Medicare Ltd is a micro-cap company in the hospital industry, incorporated in 1988, with recent quarterly net sales of 5 Cr and a net loss of 1 Cr. The company has a market cap of INR 30 Cr and operates under the name Soni Medicare Limited.

Overview: <BR>Soni Medicare Ltd operates in the hospital industry and is classified as a micro-cap company.<BR><BR>History: <BR>Soni Medicare Ltd was incorporated in 1988 as 'Soni Hospital Private Limited' and changed its name to Soni Medicare Private Limited in 1995. It later became a public limited company and adopted its current name, Soni Medicare Limited. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 5 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: -1 Cr (Quarterly Results - Jun 2026) <BR>Market-cap: INR 30 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 24 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -8.92 <BR>Return on Equity: 291.94% <BR>Price to Book: -25.10<BR><BR>Contact Details: <BR>Address: 38 Kanota Bagh, Jawahar Lal Nehru Marg Jaipur Rajasthan : 302004 <BR>Tel: 91-141-5163700 <BR>Email: jpsassociates@hotmail.com <BR>Website: http://www.sonihospitals.com

Who are the peers of the Soni Medicare?

Soni Medicare's peers include Fortis Malar, Shanmuga Hospital, KK Shah Hospital, and others. Soni Medicare has below-average management risk, growth, and capital structure, with a 1-year return of -18.43%.

Peers: The peers of Soni Medicare are Fortis Malar, Shanmuga Hos., KK Shah Hospital, Global Longlife, Broach Lifecare, Aatmaj Health, Nidan Laborator., Sangani Hospital, Maitreya Medica.<BR><BR>Quality Snapshot: Below Average management risk is observed at Fortis Malar, Soni Medicare, KK Shah Hospital, Broach Lifecare, Nidan Laborator., Maitreya Medica, and the rest. Average management risk is found at Shanmuga Hos. and Global Longlife, while Excellent management risk is observed at Shanmuga Hos. Growth is Below Average for Fortis Malar, Soni Medicare, KK Shah Hospital, Global Longlife, Broach Lifecare, Nidan Laborator., Maitreya Medica, and the rest. Average growth is seen at Shanmuga Hos. and Aatmaj Health, while Excellent growth is noted at Sangani Hospital. Capital Structure is Below Average for Fortis Malar, Soni Medicare, Global Longlife, Nidan Laborator., Maitreya Medica, and the rest, while Good capital structure is found at KK Shah Hospital, Broach Lifecare, and Aatmaj Health.<BR><BR>Return Snapshot: KK Shah Hospital has the highest 1-year return at N/A, while Global Longlife has the lowest at -55.47%. Soni Medicare's 1-year return is -18.43%, which is better than Global Longlife but worse than KK Shah Hospital. Additionally, Global Longlife has a negative six-month return of -34.46%.

How big is Soni Medicare?

As of 31st August, Soni Medicare Ltd has a market capitalization of 30.00 Cr and reported Net Sales of 21.97 Cr with a Net Profit loss of 3.62 Cr over the latest four quarters. Shareholder's Funds are 1.30 Cr, and Total Assets are 22.17 Cr.

As of 31st August, Soni Medicare Ltd has a market capitalization of 30.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Soni Medicare reported Net Sales of 21.97 Cr. However, the company experienced a loss of 3.62 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. Shareholder's Funds are recorded at 1.30 Cr, while Total Assets amount to 22.17 Cr.

Should I buy, sell or hold Soni Medicare Ltd?

When is the next results date for Soni Medicare Ltd?

The next results date for Soni Medicare Ltd is 14 August 2026.

The next results date for Soni Medicare Ltd is scheduled for 14 August 2026.

How has been the historical performance of Soni Medicare?

Soni Medicare has experienced steady revenue growth, with net sales increasing from 14.67 Cr in Mar'19 to 29.84 Cr in Mar'25, but continues to face profitability challenges, reporting a profit after tax of -0.19 Cr in Mar'25 despite improved operational efficiency. Total liabilities and assets rose to 22.17 Cr, indicating balanced growth.

Answer:<BR>The historical performance of Soni Medicare shows a fluctuating trend in its financial metrics over the years, with notable changes in revenue and profitability.<BR><BR>Breakdown:<BR>Soni Medicare's net sales have increased from 14.67 Cr in Mar'19 to 29.84 Cr in Mar'25, indicating a steady growth trajectory. Other operating income has also risen, reaching 1.35 Cr in Mar'25 from negligible amounts in previous years. Total operating income has seen a similar upward trend, climbing to 31.19 Cr in Mar'25 from 14.67 Cr in Mar'19. However, total expenditure has also increased, leading to an operating profit (PBDIT) of 1.27 Cr in Mar'25, a recovery from a loss of 0.25 Cr in Mar'24. Despite this, the company has reported a profit before tax of -0.22 Cr in Mar'25, an improvement from -1.63 Cr in Mar'24, and a profit after tax of -0.19 Cr, reflecting ongoing challenges. The company's total liabilities rose to 22.17 Cr in Mar'25, up from 19.66 Cr in Mar'24, while total assets increased to 22.17 Cr as well, indicating a balance between growth in assets and liabilities. Cash flow from operating activities turned positive at 1.00 Cr in Mar'25, contrasting with previous years where it was negative, suggesting improved operational efficiency. Overall, while Soni Medicare has shown growth in sales and operating income, it continues to face challenges in achieving profitability.

Is Soni Medicare overvalued or undervalued?

As of November 17, 2025, Soni Medicare is considered risky and overvalued due to troubling financial ratios, including a PE ratio of -43.73 and an EV to EBITDA of 51.80, despite a year-to-date stock return of 210.97% that lags behind the Sensex's 8.72% return.

As of 17 November 2025, Soni Medicare's valuation grade has moved from attractive to risky, indicating a significant shift in its financial outlook. The company appears to be overvalued, particularly given its troubling ratios, including a PE ratio of -43.73, an EV to EBITDA of 51.80, and a ROE of -76.74%. These figures suggest that the company's earnings are not only negative but also that it is trading at a high multiple relative to its earnings before interest, taxes, depreciation, and amortization.<BR><BR>In comparison to its peers, Soni Medicare's valuation stands out unfavorably. For instance, Apollo Hospitals, which is rated attractive, has a PE ratio of 64.41 and an EV to EBITDA of 33.85, while Max Healthcare is categorized as very expensive with a PE of 77.22 and an EV to EBITDA of 53.09. The stark contrast in these ratios highlights Soni Medicare's riskier position within the industry. Additionally, despite a remarkable year-to-date stock return of 210.97%, the recent performance has lagged behind the Sensex, which returned 8.72% over the same period. This combination of factors reinforces the conclusion that Soni Medicare is currently overvalued.

Are Soni Medicare latest results good or bad?

Soni Medicare's latest results show a mixed performance; while profitability has improved with a Profit After Tax of Rs 0.06 crore compared to a loss last year, the company faces challenges with declining net profit and a low Debtors Turnover Ratio, leading to a 'Sell' rating from MarketsMOJO.

Soni Medicare's latest results present a mixed picture. On one hand, the company has shown a notable improvement in profitability, reporting a Profit After Tax (PAT) of Rs 0.06 crore for the latest six-month period, a significant turnaround from a loss of Rs 1.42 crore in the previous year. This indicates that Soni Medicare has managed to surpass its PAT from the last year within just half a year, which is a positive development.<BR><BR>However, the overall financial performance for the quarter ending June 2025 has been flat, with a decline in its performance score from 3 to 2 over the past three months. Additionally, while net sales have grown by 5.97% compared to the previous quarter, the standalone net profit has seen a drastic decline of 182.86%. This suggests that while sales are increasing, the company is struggling to translate that into profit effectively.<BR><BR>Moreover, the Debtors Turnover Ratio has reached its lowest point in the last five half-yearly periods at 3.41 times, indicating challenges in managing debts and potentially impacting cash flow and operational efficiency. The stock has also been rated as a 'Sell' by MarketsMOJO, reflecting a cautious sentiment regarding the company's current performance.<BR><BR>In summary, while there are some positive signs in terms of profitability, the overall financial results indicate significant challenges that could affect the company's future performance.

What is the technical trend for Soni Medicare?

As of March 17, 2025, Soni Medicare's technical trend is bullish, supported by positive MACD and KST indicators, despite mixed signals from Bollinger Bands and Dow Theory.

As of 17 March 2025, the technical trend for Soni Medicare has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. The KST is also bullish on both time frames, reinforcing the bullish stance. While the Bollinger Bands indicate a mildly bullish position on both weekly and monthly charts, the daily moving averages are only mildly bullish. The Dow Theory presents a mixed view, being mildly bearish on the weekly chart but bullish on the monthly chart. Overall, the current technical stance is bullish, with strong support from MACD and KST indicators, despite some mixed signals from other indicators.

Who are the top shareholders of the Soni Medicare?

The top shareholder of Soni Medicare is B R Soni, holding 39.1% of the shares, with Sahil Chabra as the highest public shareholder at 4.69%. Individual investors collectively own 25.15% of the shares, and there are no pledged promoter holdings or institutional investors.

The top shareholders of Soni Medicare include the promoters, with B R Soni holding the highest stake at 39.1%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors holding shares. The highest public shareholder is Sahil Chabra, who owns 4.69%. Additionally, individual investors collectively hold 25.15% of the shares.

Has Soni Medicare declared dividend?

No Dividend History Available